Charles River Laboratories International, Inc.

Location

Massachusetts

Founded

1947-02-28

Risk Signals

1057 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Charles River Laboratories International, Inc.

Live alerts from global media, monitored by Business Radar

AI identifies new product candidate for lupus - Drug Discovery World (DDW)

2025-04-01 (ddw-online.com)

AI identifies new product candidate for lupus - Drug Discovery World (DDW)

Charles River Laboratories and Valo Health have announced the identification of an advanceable product candidate for the treatment of different forms of lupus and other autoimmune indications.

Read more
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call | Business Wire

2025-01-28 (businesswire.com)

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call | Business Wire

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

Read more
Charles River Laboratories' Quarterly Earnings Preview: What You Need to Know |

2025-01-24 (nasdaq.com)

Charles River Laboratories' Quarterly Earnings Preview: What You Need to Know |

Charles River Laboratories will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Read more
Cell Bank Creation Service Market Overall Study Report 2025-2032 | BioReliance by Merck, Charles River Laboratories International, Inc., Corning Incorporated

2025-01-23 (openpr.com)

Cell Bank Creation Service Market Overall Study Report 2025-2032 | BioReliance by Merck, Charles River Laboratories International, Inc., Corning Incorporated

Press release - Coherent Market Insights - Cell Bank Creation Service Market Overall Study Report 2025-2032 | BioReliance by Merck, Charles River Laboratories International, Inc., Corning Incorporated - published on openPR.com

Read more
Charles River Labs Launches Apollo Platform to Transform Drug Research Operations | CRL Stock News

2025-01-21 (stocktitan.net)

Charles River Labs Launches Apollo Platform to Transform Drug Research Operations | CRL Stock News

Charles River introduces Apollo™, a cloud-based platform revolutionizing vivarium services and drug development workflows with real-time access to critical research tools and data.

Read more
Global Alternative Investment Software Market Size, Share and Forecast By Key Players-BlackRock,Charles River,SS&C Technologies,Iress,Murex

2025-01-09 (openpr.com)

Global Alternative Investment Software Market Size, Share and Forecast By Key Players-BlackRock,Charles River,SS&C Technologies,Iress,Murex

Press release - Market Research Intellect - Global Alternative Investment Software Market Size, Share and Forecast By Key Players-BlackRock,Charles River,SS&C Technologies,Iress,Murex - published on openPR.com

Read more
Clinical Research Organisation CRO Market Size, Insights 2031 by Key Vendors- Charles River Laboratories, IQVIA, LabCorp

2025-01-07 (openpr.com)

Clinical Research Organisation CRO Market Size, Insights 2031 by Key Vendors- Charles River Laboratories, IQVIA, LabCorp

Press release - Verified Market Reports - Clinical Research Organisation CRO Market Size, Insights 2031 by Key Vendors- Charles River Laboratories, IQVIA, LabCorp - published on openPR.com

Read more
Biostatistics Consulting Service Market Top Players - IQVIA Parexel are Charles River, ACM Global, Celerion, Clinitude, Covance.

2024-12-16 (openpr.com)

Biostatistics Consulting Service Market Top Players - IQVIA Parexel are Charles River, ACM Global, Celerion, Clinitude, Covance.

Press release - InsightAce Analytic Pvt. Ltd - Biostatistics Consulting Service Market Top Players - IQVIA Parexel are Charles River, ACM Global, Celerion, Clinitude, Covance. - published on openPR.com

Read more
Patient Derived Xenograft Model Market Is Booming Worldwide 2024-2031 | THE JACKSON LABORATORY, Champions Oncology, Inc, Charles River Laboratories

2024-12-06 (openpr.com)

Patient Derived Xenograft Model Market Is Booming Worldwide 2024-2031 | THE JACKSON LABORATORY, Champions Oncology, Inc, Charles River Laboratories

Press release - Coherent Market Insights - Patient Derived Xenograft Model Market Is Booming Worldwide 2024-2031 | THE JACKSON LABORATORY, Champions Oncology, Inc, Charles River Laboratories - published on openPR.com

Read more

Never miss a headline about Charles River Laboratories International, Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages